Mesenchymal Stem Cell–Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma
Investigative Ophthalmology & Visual Science2018Vol. 59(2), pp. 702–702
Citations Over TimeTop 10% of 2018 papers
Abstract
Injection of BMSC-derived sEV into the vitreous provided significant therapeutic benefit to glaucomatous eyes. The neuroprotective effect of sEV, at least partially, may be explained by direct action on RGC through miRNA-dependent mechanisms.
Related Papers
- → Neuroprotective Properties of Chitosan and Its Derivatives(2010)165 cited
- → Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities(2015)81 cited
- → Neuroprotective effects of the survival promoting peptide Y-P30(2009)8 cited
- Protective mechanisms for endogenous retinal ganglion cells(2009)
- POTENTIAL NEUROPROTECTIVE EFFECTS OF HERBAL COMPOUNDS(2015)